Cleared Traditional

K941198 - EBV LGG ELISA TEST
(FDA 510(k) Clearance)

Aug 1995
Decision
527d
Days
Class 1
Risk

K941198 is an FDA 510(k) clearance for the EBV LGG ELISA TEST. This device is classified as a Epstein-barr Virus, Other (Class I - General Controls, product code LSE).

Submitted by Gull Laboratories, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on August 23, 1995, 527 days after receiving the submission on March 14, 1994.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3235.

Submission Details

510(k) Number K941198 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 14, 1994
Decision Date August 23, 1995
Days to Decision 527 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code LSE — Epstein-barr Virus, Other
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3235

Similar Devices — LSE Epstein-barr Virus, Other

All 55
ADVIA Centaur EBV-VCA IgM
K233606 · Biokit, S.A. · Aug 2024
LIAISON? VCA IgG and LIAISON? VCA IgG Serum Control Set; LIAISON? EBNA IgG and LIAISON? EBNA IgG Serum Control Set
K162961 · DiaSorin, Inc. · Jan 2017
LIAISON? EA IgG and LIAISON? EA IgG Serum Control Set
K162959 · DiaSorin, Inc. · Jan 2017
SERAQUEST EBV EA-D IGG TEST
K091260 · Quest Intl., Inc. · Jun 2009
PLEXUS EBV IGG MULTI-ANALYTE DIAGNOSTICS, MODEL: MP0500G
K073382 · Focus Diagnostics, Inc. · Jul 2008
BIOPLEX 2200 EBV IGG PANEL FOR BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM
K062211 · Bio-Rad Laboratories, Inc. · Dec 2006